Target validation using chemical probes

被引：329

作者：

Bunnage, Mark E. ^{[1
]}

Chekler, Eugene L. Piatnitski ^{[1
]}

Jones, Lyn H. ^{[1
]}

机构：

[1] Pfizer, Worldwide Med Chem, Cambridge, MA USA

来源：

NATURE CHEMICAL BIOLOGY | 2013年 / 9卷 / 04期

关键词：

SMALL MOLECULES; INHIBITOR; IDENTIFICATION; PROTEOMICS; DISCOVERY; POTENT;

D O I：

10.1038/nchembio.1197

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fully profiled chemical probes are essential to support the unbiased interpretation of biological experiments necessary for rigorous preclinical target validation. We believe that by developing a 'chemical probe tool kit', and a framework for its use, chemical biology can have a more central role in identifying targets of potential relevance to disease, avoiding many of the biases that complicate target validation as practiced currently.

引用

页码：195 / 199

页数：5

共 31 条

[11] The art of the chemical probe [J].

Frye, Stephen V. .

NATURE CHEMICAL BIOLOGY, 2010, 6 (03) :159-161

[12] Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect [J].

Gao, Min ;

Nettles, Richard E. ;

Belema, Makonen ;

Snyder, Lawrence B. ;

Nguyen, Van N. ;

Fridell, Robert A. ;

Serrano-Wu, Michael H. ;

Langley, David R. ;

Sun, Jin-Hua ;

O'Boyle, Donald R. ;

Lemm, Julie A. ;

Wang, Chunfu ;

Knipe, Jay O. ;

Chien, Caly ;

Colonno, Richard J. ;

Grasela, Dennis M. ;

Meanwell, Nicholas A. ;

Hamann, Lawrence G. .

NATURE, 2010, 465 (7294) :96-U108

[13] The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy [J].

Honigberg, Lee A. ;

Smith, Ashley M. ;

Sirisawad, Mint ;

Verner, Erik ;

Loury, David ;

Chang, Betty ;

Li, Shyr ;

Pan, Zhengying ;

Thamm, Douglas H. ;

Miller, Richard A. ;

Buggy, Joseph J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (29) :13075-13080

[14]

Jones Lyn H, 2011, J Chem Biol, V4, P49, DOI 10.1007/s12154-010-0047-1

[15] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997) [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :3-26

[16] Drugs that induce repolarization abnormalities cause bradycardia in zebrafish [J].

Milan, DJ ;

Peterson, TA ;

Ruskin, JN ;

Peterson, RT ;

MacRae, CA .

CIRCULATION, 2003, 107 (10) :1355-1358

[17] Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival [J].

Morgan, Paul ;

Van der Graaf, Piet H. ;

Arrowsmith, John ;

Feltner, Doug E. ;

Drummond, Kira S. ;

Wegner, Craig D. ;

Street, Steve D. A. .

DRUG DISCOVERY TODAY, 2012, 17 (9-10) :419-424

[18] Suppression of inflammation by a synthetic histone mimic [J].

Nicodeme, Edwige ;

Jeffrey, Kate L. ;

Schaefer, Uwe ;

Beinke, Soren ;

Dewell, Scott ;

Chung, Chun-wa ;

Chandwani, Rohit ;

Marazzi, Ivan ;

Wilson, Paul ;

Coste, Herve ;

White, Julia ;

Kirilovsky, Jorge ;

Rice, Charles M. ;

Lora, Jose M. ;

Prinjha, Rab K. ;

Lee, Kevin ;

Tarakhovsky, Alexander .

NATURE, 2010, 468 (7327) :1119-1123

[19] Zebrafish developmental screening of the ToxCast™ Phase I chemical library [J].

Padilla, S. ;

Corum, D. ;

Padnos, B. ;

Hunter, D. L. ;

Beam, A. ;

Houck, K. A. ;

Sipes, N. ;

Kleinstreuer, N. ;

Knudsen, T. ;

Dix, D. J. ;

Reif, D. M. .

REPRODUCTIVE TOXICOLOGY, 2012, 33 (02) :174-187

[20] In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases [J].

Patricelli, Matthew P. ;

Nomanbhoy, Tyzoon K. ;

Wu, Jiangyue ;

Brown, Heidi ;

Zhou, David ;

Zhang, Jianming ;

Jagannathan, Subadhra ;

Aban, Arwin ;

Okerberg, Eric ;

Herring, Chris ;

Nordin, Brian ;

Weissig, Helge ;

Yang, Qingkai ;

Lee, Jiing-Dwan ;

Gray, Nathanael S. ;

Kozarich, John W. .

CHEMISTRY & BIOLOGY, 2011, 18 (06) :699-710

← 1 2 3 4 →